首页/数据集/Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.

Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.

Figshare2025-10-09 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Baseline_and_Post-Treatment_Serum_Levels_of_NT-proBNP_in_Each_Investigational_Group_/30322592 数据链接链接失效反馈

官方服务：

资源简介：

Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.

应用场景：

创建时间：

2025-10-09

抗逆转录病毒治疗

临床疗效评估

ART = antiretroviral therapy. OR = odds ratio. VL = viral load. CI = confidence interval. MSF/MoH = Médecins Sans Frontières/Ministry of Health.

NIAID Data Ecosystem50

Characteristics of the five studies included in the meta-analysis of PTX3 and CRP in TAK activity assessment.

血管生物标志物

荟萃分析研究

Characteristics of the five studies included in the meta-analysis of PTX3 and CRP in TAK activity assessment.

Figshare2021-02-02 更新40

Association between the M-CHARTS score 12 months after initiating intravitreal ranibizumab therapy and baseline parameters in eyes with branch retinal vein occlusion.

视网膜静脉阻塞

临床疗效评估

Association between the M-CHARTS score 12 months after initiating intravitreal ranibizumab therapy and baseline parameters in eyes with branch retinal vein occlusion.

Figshare2018-09-20 更新20

An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer

结直肠癌辅助化疗

临床疗效评估

This observational study evaluates the efficacy and safety of capecitabine in combination with oxaliplatin in the adjuvant setting in participants with Stage III colon cancer. Data were collected from

NIAID Data Ecosystem40

Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).

临床疗效评估

医疗质量指标

Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).

Figshare2022-11-02 更新30